Back
Royal Caribbean Group Vs. Vera Therapeutics Industry Stock Comparison
Buy
81
RCL
Royal Caribbean Group
Last Price:
210.07
Seasonality Move:
11.63%
Buy
88
VERA
Vera Therapeutics
Last Price:
42.92
Seasonality Move:
61.56%
Buy
81
Royal Caribbean Group (RCL)
is a Buy
Is Royal Caribbean Group a Buy, Sell or Hold?
- The current Royal Caribbean Group [RCL] share price is $203.52. The Score for RCL is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- RCL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
88
Vera Therapeutics (VERA)
is a Buy
Is Vera Therapeutics a Buy, Sell or Hold?
- The current Vera Therapeutics [VERA] share price is $47.34. The Score for VERA is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
- VERA is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
RCL Stock Price Chart
What is Royal Caribbean Group's stock price today?
-
The Royal Caribbean Group share price today is $203.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCL is experiencing slight selling pressure.
VERA Stock Price Chart
What is Vera Therapeutics's stock price today?
-
The Vera Therapeutics share price today is $47.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VERA is experiencing slight selling pressure.
RCL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.26 | Buy |
Relative Strength Index (14 RSI): | 70.54 | Buy |
Chaikin Money Flow: | -964628 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (177.82 - 200.56) | Buy |
Bollinger Bands (100): | (151.16 - 182.1) | Buy |
VERA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.5 | Buy |
Relative Strength Index (14 RSI): | 68.62 | Buy |
Chaikin Money Flow: | -472447 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.44 - 44.12) | Buy |
Bollinger Bands (100): | (35.42 - 41.2) | Buy |
RCL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 201.7 | Buy |
20-day SMA: | 191.82 | Buy |
50-day SMA: | 176.32 | Buy |
200-day SMA: | 149.28 | Buy |
8-day EMA: | 200.73 | Buy |
20-day EMA: | 193.41 | Buy |
50-day EMA: | 180.53 | Buy |
200-day EMA: | 151.8 | Buy |
VERA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.35 | Buy |
20-day SMA: | 40.98 | Buy |
50-day SMA: | 40.37 | Buy |
200-day SMA: | 38.92 | Buy |
8-day EMA: | 42.05 | Buy |
20-day EMA: | 41.35 | Buy |
50-day EMA: | 40.39 | Buy |
200-day EMA: | 35.83 | Buy |
Royal Caribbean Group Earnings Growth & RCL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.95 per share, and an increase next year of $2.06 per share.
Vera Therapeutics Earnings Growth & VERA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and a decrease next year of $0.01 per share.
Royal Caribbean Group Technical Analysis
Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vera Therapeutics Technical Analysis
Oct 15 | Oct 16 | Oct 17 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |